| Literature DB >> 32622770 |
Ramin Pourakbari1, Sanaz Mansouri Taher2, Bashir Mosayyebi3, Mohammad Hosein Ayoubi-Joshaghani3, Hamid Ahmadi4, Leili Aghebati-Maleki5.
Abstract
Glycosylated compounds are major secondary metabolites of plants, which have various therapeutic effects on human diseases, by acting as anti-cancer, antioxidant, and anti-inflammatory agents. Glycosylation increases stability, bioactivity, and solubility of compounds and improves their pharmacological properties. Two well-known examples of glycosylated compounds include cardiac and flavonoid, the anti-tumor activities of which have been emphasized by several studies. However, little is known about their role in the treatment or prevention of cancer. In this review, recent studies on anti-tumor properties of cardiac and flavonoid glycosides, and their mechanisms of action, have been investigated. More specifically, this review is aimed at focusing on the multifactorial properties of cardiac and flavonoid compounds as well as their correlation with signaling pathways in the treatment of cancer.Entities:
Keywords: Cardiac glycoside; Flavonoid glycoside; Glycosylated compounds
Mesh:
Substances:
Year: 2020 PMID: 32622770 DOI: 10.1016/j.ijbiomac.2020.06.281
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953